This inventor holds 1 USPTO granted patent and 3 published patent applications. Top assignee: Avelos Therapeutics Inc.. Active years: 2026.
Company Filing History:
Years Active: 2026
Title: Ki Seon Baek: Innovator in Pharmaceutical Compounds
Introduction
Ki Seon Baek is a prominent inventor based in Seoul, South Korea. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds that target specific medical conditions.
Latest Patents
One of his notable patents is titled "Preparation of substituted 1,2-diaminoheterocyclic compound derivatives and their use as pharmaceutical agents." This invention focuses on compounds that act as microtubule associated serine/threonine-like kinase (MASTL) inhibitors. The compounds developed by Baek are intended for use in treating diseases and medical conditions mediated by MASTL, including cancer and other related diseases.
Career Highlights
Ki Seon Baek is currently associated with Avelos Therapeutics Inc., where he continues to innovate in the pharmaceutical sector. His work is characterized by a commitment to advancing medical treatments through innovative compound development.
Collaborations
He collaborates with talented individuals such as Young Whan Park and Samuele Maramai, contributing to a dynamic research environment that fosters innovation.
Conclusion
Ki Seon Baek's contributions to pharmaceutical inventions highlight his role as a key innovator in the field. His work on MASTL inhibitors represents a significant advancement in the treatment of critical medical conditions.